Innovative Therapies
Innovative Therapies 2017-11-30T11:07:29+00:00

We are a clinical stage company, developing a compelling portfolio of innovative gene therapy products for people with serious, life-threatening rare diseases.

Indication
Stage of Development
Proof-of-Concept
IND Enabling
Phase 1/2
Commercial Rights
Audentes Therapeutics
Audentes Therapeutics
Audentes Therapeutics
Audentes Therapeutics
Indication: XLMTM
Phase 1
Audentes Therapeutics
Phase 1
Audentes Therapeutics
Indication: Pompe Disease
IND Enabling
Audentes Therapeutics
Indication: CASQ2-CPVT
IND Enabling
Audentes Therapeutics